Li Lingxi, Hu Muni, Zhu Xiaoqiang, Huang Xiaowen, Chen Haoyan
State Key Laboratory of Systems Medicine for Cancer, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai Cancer Institute, Shanghai, China.
Methods Mol Biol. 2025;2930:295-306. doi: 10.1007/978-1-0716-4558-1_21.
This protocol outlines the standardized procedures for utilizing fecal microbiota transplantation (FMT) in tumor immunology studies. FMT, the process of transferring gut microbiota from a healthy donor to a recipient, has shown potential in modulating the immune response against tumors. This protocol details the selection criteria for donors and recipients, preparation and processing of fecal material, and the administration routes for transplantation. Additionally, it describes the pre- and posttransplantation monitoring of microbiota composition, immune parameters, and tumor progression. By following this protocol, researchers can systematically investigate the impact of microbiota on tumor growth and immune modulation, contributing to the development of microbiota-based therapeutic strategies in oncology.
本方案概述了在肿瘤免疫学研究中使用粪便微生物群移植(FMT)的标准化程序。FMT是将肠道微生物群从健康供体转移到受体的过程,已显示出在调节抗肿瘤免疫反应方面的潜力。本方案详细介绍了供体和受体的选择标准、粪便材料的制备和处理以及移植的给药途径。此外,它还描述了移植前后对微生物群组成、免疫参数和肿瘤进展的监测。通过遵循本方案,研究人员可以系统地研究微生物群对肿瘤生长和免疫调节的影响,为肿瘤学中基于微生物群的治疗策略的发展做出贡献。